logo
  

SK Telecom Partners With Aptos, Brevan Howard, Microsoft To Launch Aptos Ascend For Financial Market

SK Telecom (SKM) announced a collaboration with Aptos Labs, Brevan Howard, and Microsoft to introduce Aptos Ascend, a comprehensive suite of institutional solutions for the global financial market.

The partnership integrates SKT's Wallet-as-a-Service product and the secure Aptos blockchain to deliver end-to-end solutions, including a permissioned network and Digital Asset Controls.

With Brevan Howard's expertise, Aptos Ascend aims to facilitate digital currency and asset management for banks and financial institutions responsibly and at scale.

Boston Consulting Group (BCG) joins as Aptos Labs' consulting partner, leveraging its global proficiency in decentralized finance, digital assets, and AI to implement the solutions.

The suite, powered by Microsoft Azure and Azure OpenAI Service, along with SKT's regulatory-compliant Web3 technology, promises innovative trade finance offerings within a decentralized, scalable, and data-rich network.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, Kraft Heinz Co. (KHC) reaffirmed its adjusted earnings and organic net sales growth guidance for the full-year 2024. For fiscal 2024, the company still projects adjusted earnings in a range of $3.01 to $3.07 per share on organic... While reporting financial results for the first quarter, drug major Pfizer Inc. (PFE) raised its adjusted earnings guidance for the full-year 2024, while maintaining annual revenue outlook. For fiscal 2024, the company now projects adjusted earnings in a range of $2.15 to $2.35 per share, up from... While reporting financial results for the first quarter on Wednesday, CVS Health (CVS) slashed its earnings and adjusted earnings guidance for the full-year 2024, reflecting the potential for continued elevated medical cost trends in the remainder of 2024. For fiscal 2024, the company now projects...

This week, we feature OJEMDA’s FDA approval, Bristol Myer’s Job cuts, Novo Nordisk’s increased pricing of drugs in US, Incyte’s strategic acquisition, and Ireland’s Alcohol labels.

View More Videos
Follow RTT